Ralf Wilkowski

2.3k citations
48 papers · 1.8k indexed · 1 hit paper · h-index 25

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

Ralf Wilkowski

46 papers receiving 1.8k citations

Hit Papers

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer 2006 · 535 citations
5350+6+13Years since publication100200300400500

Peers

Ralf Wilkowski
Comparison fields: 5 of 87
  • Oncology 1.3k
  • Cancer Research 524
  • Pulmonary and Respiratory Medicine 533
  • Epidemiology 502
  • Hepatology 95
Replace Bernd Doerken with:
Bernd Doerken Germany
Robert Marsh United States
Anna M. Varghese United States
Mukund S. Didolkar United States
Frédèric Selle France
L. Roll Germany
Suzanne Russo United States
Vicente Alonso Spain
Marianne Sinn Germany
Tatsuya Yoshida Japan
Ralf Wilkowski relative to Bernd Doerken Germany Bernd Doerken's profile →
Citations per field
00.5×1.5×1.8×
Bernd Doerken · 1×
Citations per year

Countries citing papers authored by Ralf Wilkowski

Since Specialization
Citations

This map shows the geographic impact of Ralf Wilkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Wilkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Wilkowski more than expected).

Fields of papers citing papers by Ralf Wilkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Wilkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Wilkowski. The network helps show where Ralf Wilkowski may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralf Wilkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralf Wilkowski Line = papers co-authored together Ralf Wilkowski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
Hit paper breakdown →
2006535
2 2006138
3 2008114
4 200893
5 200357
6
Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.
200657
7
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.
199952
8 199650
9 200447
10 201045
11 200743
12
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
200643
13 200942
14 200739
15 200336
16 200536
17 201035
18 201033
19 201032
20 200832

About Ralf Wilkowski

Ralf Wilkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Surgery, having authored 48 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Cancer Genomics and Diagnostics (14 papers), Neuroendocrine Tumor Research Advances (12 papers), Renal cell carcinoma treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatitis Pathology and Treatment (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (524 citations), Pulmonary and Respiratory Medicine (533 citations), Epidemiology (502 citations) and Hepatology (95 citations). Ralf Wilkowski has collaborated with scholars based in Germany, Netherlands and Italy. Frequent co-authors include Volker Heinemann, P Stieber, Stefan Holdenrieder, Andreas Schalhorn, Christiane J. Bruns, Stefan Boeck, Martin Thoma, Axel Hinke, Horst Neuhaus and A. Rost. Their work appears in journals such as Journal of Clinical Oncology, Tumor Biology, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research and Strahlentherapie und Onkologie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact